Protective effect of astragaloside IV on lipopolysaccharide-induced cardiac dysfunction via downregulation of inflammatory signaling in mice

Immunopharmacology and Immunotoxicology

Volumn 37, Issue 5, 2015, Pages 428-433

  Zhao, Peng ^a,b   Wang, Ying ^b   Zeng, Shan ^b   Lu, Jie ^b   Jiang, Tie Min ^b   Li, Yu Ming ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b MEDICAL COLLEGE OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

Author keywords

Astragaloside IV; cardiac dysfunction; NF B; PI3K Akt signaling; sepsis septic shock

Indexed keywords

ASTRAGALOSIDE IV; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA; ASTRAGALOSIDE A; CYTOKINE; LIPOPOLYSACCHARIDE; ONCOPROTEIN; RELA PROTEIN, MOUSE; SAPONIN; TRANSCRIPTION FACTOR RELA; TRITERPENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARDITIS; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE PERFORMANCE; HEART PROTECTION; LACTATE DEHYDROGENASE BLOOD LEVEL; LIFESPAN; LIPOPOLYSACCHARIDE INDUCED CARDIAC DYSFUNCTION; MALE; MORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; BLOOD; CARDIAC MUSCLE; CHEMICALLY INDUCED; DRUG EFFECTS; HEART DISEASES; INFLAMMATION; METABOLISM;

ANIMALS; CYTOKINES; HEART DISEASES; INFLAMMATION; LIPOPOLYSACCHARIDES; MICE; MYOCARDIUM; ONCOGENE PROTEIN V-AKT; SAPONINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TRITERPENES;

EID: 84944352139     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2015.1080266     Document Type: Article

References (25)

1. Merx MW, Weber C. Sepsis and the heart. Circulation 2007;116: 793-802.
2. Bone R, Balk R, Cerra F, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1644-1655.
3. Watanabe Y, Shibata R, Ouchi N, et al. Adiponectin ameliorates endotoxin-induced acute cardiac injury. Biomed Res Int 2014;2014: 382035.
4. Zanotti-Cavazzoni SL, Hollenberg SM. Cardiac dysfunction in severe sepsis and septic shock. Curr Opin Crit Care 2009;15: 392-397.
5. Kang-Woo L, So Young J, Sun-Mi C, Eun Jin Y. Effects of ginsenoside Re on LPS-induced inflammatory mediators in BV2 microglial cells. BMC Comp Alt Med 2012;12:196.
6. Avlas O, Fallach R, Shainberg A, et al. Toll-like receptor 4 stimulation initiates an inflammatory response that decreases cardiomyocyte contractility. Antioxid Redox Signal 2011;15: 1895-1909.
7. Sun B, Xiao J, Sun XB, Wu Y. Notoginsenoside R1 attenuates cardiac dysfunction in endotoxemic mice: an insight into oestrogen receptor activation and PI3K/Akt signalling. Br J Pharmacol 2013; 168:1758-1770.
8. Liu CJ, Lo JF, Kuo CH, et al. Akt mediates 17beta-estradiol and/or estrogen receptor-alpha inhibition of LPS-induced tumor necrosis factor-alpha expression and myocardial cell apoptosis by suppressing the JNK1/2-NFkappaB pathway. J Cell Mol Med 2009;13: 3655-3667.
9. Dong M, Hu N, Hua Y, et al. Chronic Akt activation attenuated lipopolysaccharide-induced cardiac dysfunction via Akt/GSK3beta-dependent inhibition of apoptosis and ER stress. Biochim Biophys Acta 2013;1832:848-863.
10. Kwon HJ, Park YD. Determination of astragalin and astragaloside content in Radix Astragali using high-performance liquid chromatography coupled with pulsed amperometric detection. J Chromatogr A 2012;1232:212-217.
11. Tohda C, Tamura T, Matsuyama S, Komatsu K. Promotion of axonal maturation and prevention of memory loss in mice by extracts of Astragalus mongholicus. Br J Pharmacol 2006;149: 532-541.
12. Zhao Y, Li Q, Zhao W, et al. Astragaloside IV and cycloastragenol are equally effective in inhibition of endoplasmic reticulum stressassociated TXNIP/NLRP3 inflammasome activation in the endothelium. J Ethnopharmacol 2015;169:210-218.
13. Ji K, Chen J, Hu J, et al. The protective effect of astragaloside IV against benzo[a]pyrene induced endothelial progenitor cell dysfunction. Life Sci 2015;132:13-19.
14. He CL, Yi PF, Fan QJ, et al. Xiang-Qi-Tang and its active components exhibit anti-inflammatory and anticoagulant properties by inhibiting MAPK and NF-kappaB signaling pathways in LPS-treated rat cardiac microvascular endothelial cells. Immunopharmacol Immunotoxicol 2013;35:215-224.
15. Wang S-G, Xu Y, Xie H, et al. Astragaloside IV prevents lipopolysaccharide-induced injury in H9C2 cardiomyocytes. Chin J Nat Med 2015;13:127-132.
16. Hessel MH, Atsma DE, van der Valk EJ, et al. Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation. Pflugers Arch 2008;455:979-986.
17. Ha T, Lu C, Liu L, et al. TLR2 ligands attenuate cardiac dysfunction in polymicrobial sepsis via a phosphoinositide 3-kinase-dependent mechanism. Am J Physiol Heart Circ Physiol 2010;298:H984-H991.
18. Landesberg G, Gilon D, Meroz Y, et al. Diastolic dysfunction and mortality in severe sepsis and septic shock. Eur Heart J 2012;33: 895-903.
19. Luan A, Tang F, Yang Y, et al. Astragalus polysaccharide attenuates isoproterenol-induced cardiac hypertrophy by regulating TNFalpha/ PGC-1alpha signaling mediated energy biosynthesis. Environ Toxicol Pharmacol 2015;39:1081-1090.
20. Xiang Li, Lijing Jiang, Shenghui Lin, et al. Inhibition of mTORC1 renders cardiac protection against lipopolysaccharide. Int J Clin Exp Pathol 2014;7:8432-8442.
21. Flierl MA, Rittirsch D, Huber-Lang MS, et al. Molecular events in the cardiomyopathy of sepsis. Mol Med 2008;14:327-336.
22. Horton J, Maass D, White J, Sanders B. Nitric oxide modulation of TNF-alpha-induced cardiac contractile dysfunction is concentration dependent. Am J Physiol Heart Circ Physiol 2000;278: H1955-H1965.
23. Kolattukudy PE, Quach T, Bergese S, et al. Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle. Am J Pathol 1998;152:101-111.
24. Kawai T, Akira S. Signaling to NF-kB by Toll-like receptors. Trends Mol Med 2007;13:460-469.
25. Jiang S, Zhu W, Li C, et al. alpha-Lipoic acid attenuates LPSinduced cardiac dysfunction through a PI3K/Akt-dependent mechanism. Int Immunopharmacol 2013;16:100-107.